The School of Medicine’s Medical Advisory Committee (MAC) met on June 11, 2019, 4-5 p.m., in the Biomedical Sciences classroom. Here are highlights from that meeting:
David S. Wilkes, MD | Dean
Dean Wilkes announced Reid B. Adams, MD, as the new chair of the Department of Surgery.
The Leapfrog Group has given the UVA hospital a safety grade of A. Dean Wilkes thanked everyone for their diligent efforts leading to this grade.
Dexcom has purchased the technology behind the UVA-led Artificial Pancreas Study. The technology, which was developed at UVA, will improve the lives of people with Type 1 diabetes throughout the world.
Health System Development is partnering with Plus Delta Partners to pair faculty with frontline development professionals for targeted coaching. The goal is increased success in philanthropic efforts across all missions. While the development professionals will begin the coaching this summer, the first cohort of 20 faculty members will begin participating in November.
Marketing Creative Strategy
Patricia Cluff | Chief, Strategic Relations and Marketing
Ms. Cluff presented the new marketing campaign, which is a logical extension of the earlier campaigns of Beyond Measure and Tomorrow Can’t Wait. The campaign will build on the consumer’s view of the UVA Health System being the preferred provider in our region, and will tell stories that convey experience, passion, a sense of pride and service. In addition, we will implement updated marks to transition from UVA Health System to UVA Health and UVA Children’s Hospital to UVA Children’s.
General Assembly and Federal Government Update
Carol Craig | Government Relations Specialist
Lynne Boyle | Federal Relations Professional
The Health System Office of State and Federal Government Relations works with Health System leadership to establish legislative and regulatory priorities, maintains relations with government officials, coordinates with the academic division, and serves as a resource for members of the Health System. Dr. Karen Rheuban serves as the School of Medicine liaison to the office.
The top federal issues in research are FY20 funding for the NIH, reauthorization of funding for the Patient Center Outcomes Research Institute, and foreign threats. In the area of health care, lowering the cost of health care and improving transparency are priorities. These include drug pricing, price transparency, surprise billing, and regulation of private contracts between health plans and providers.
At the state level, newly enacted legislation includes Surprise/Balance Billing (HB 2538), Price Transparency – Estimates on Elective Procedures (HB 2750/SB1004), Physician Assistants – Supervision Changes (HB 1952/SB 1209), and CBD/THC-a Oil (SB 1557; SB 1719).
More information is available on the website.
Health System Board Update
A. Bobby Chhabra, MD | Chair, Department of Orthopaedic Surgery
At the June 6, 2019, Health System Board meeting, the members were informed of the Leapfrog A grade, the inclusion of the hospital in the Becker’s Hospital 100 Great Hospitals 2019 list, the induction of Edward Egelman, PhD, into the National Academy of Sciences, and the third-floor renovations of Pinn Hall.
The Operational Goals dashboard was presented, as were the third-quarter FY19 financials and the proposed FY20 budget.
The next meeting will be Tuesday, July 9, 2019, in the BIMS Classroom.